ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance.
International journal of cancer
View this publicationInternational journal of cancer
View this publicationClinical drug investigation
View this publicationCellular immunology
View this publicationJournal of the European Academy of Dermatology and Venereology : JEADV
View this publicationCell death & disease
View this publicationMolecular metabolism
View this publicationEuropean heart journal supplements : journal of the European Society of Cardiology
View this publicationBioinformatics (Oxford, England)
View this publicationPediatric radiology
View this publicationThe Journal of infectious diseases
View this publication